Pharmaceutical

PDS-01ADC by PDS Biotechnology for Colorectal Cancer: Likelihood of Approval

PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Colorectal Cancer.

Jan 3, 2024 - 18:00
PDS-01ADC by PDS Biotechnology for Colorectal Cancer: Likelihood of Approval
PDS-01ADC is under clinical development by PDS Biotechnology and currently in Phase II for Colorectal Cancer.
Read the original article

Tags:

Previous Article

MediLink and Roche partner on cancer drug development

Next Article

Roche buys Point-of-Care Technology Platform from LumiraDx

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

FDA approves Vertex’s gene-edited therapy for beta thalassemia

FDA approves Vertex’s gene-edited therapy for beta thal...

Jan 17, 2024

STAT+: Gilead and Teva defeat antitrust lawsuit that claimed prices for HIV medicines were unfairly kept high

STAT+: Gilead and Teva defeat antitrust lawsuit that cl...

Jun 30, 2023

Flagship Pioneering collaborates with Pfizer to develop new therapies

Flagship Pioneering collaborates with Pfizer to develop...

Jul 19, 2023